InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.69+0.04 (+5.48%)
Close on Nov 18, 2026Market cap $31.87MP/E –Yield –
InspireMD shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
InspireMD's shares outstanding was 85M at Jun 30, 2026. For fiscal 2025 it was 64M, up 53.4% from the year before. Over ten years it grew 375.0% a year on average. The highest annual figure on record is 64M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64M | +53.4% |
| FY2024 | Dec 31, 2024 | 42M | +72.8% |
| FY2023 | Dec 31, 2023 | 24M | +208.3% |
| FY2022 | Dec 31, 2022 | 8M | +7.2% |
| FY2021 | Dec 31, 2021 | 7M | +385.7% |
| FY2020 | Dec 31, 2020 | 2M | +985.5% |
| FY2019 | Dec 31, 2019 | 0M | +352.8% |
| FY2018 | Dec 31, 2018 | 0M | +6090.9% |
| FY2017 | Dec 31, 2017 | 0M | +820.4% |
| FY2016 | Dec 31, 2016 | 0M | +390.9% |
| FY2015 | Dec 31, 2015 | 0M | +266.7% |
| FY2013 | Jun 30, 2013 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 85M | +66.0% |
| Q1 FY2026 | Mar 31, 2026 | 84M | +67.6% |
| Q4 FY2025 | Dec 31, 2025 | 83M | +66.9% |
| Q3 FY2025 | Sep 30, 2025 | 73M | +51.9% |
| Q2 FY2025 | Jun 30, 2025 | 51M | +42.2% |
| Q1 FY2025 | Mar 31, 2025 | 50M | +46.0% |
| Q4 FY2024 | Dec 31, 2024 | 49M | +47.1% |
| Q3 FY2024 | Sep 30, 2024 | 48M | +42.3% |
| Q2 FY2024 | Jun 30, 2024 | 36M | +70.2% |
| Q1 FY2024 | Mar 31, 2024 | 34M | +323.1% |
| Q4 FY2023 | Dec 31, 2023 | 34M | +318.4% |
| Q3 FY2023 | Sep 30, 2023 | 34M | +333.6% |
| Q2 FY2023 | Jun 30, 2023 | 21M | +169.9% |
| Q1 FY2023 | Mar 31, 2023 | 8M | +3.7% |
| Q4 FY2022 | Dec 31, 2022 | 8M | +3.0% |
| Q3 FY2022 | Sep 30, 2022 | 8M | +1.3% |
| Q2 FY2022 | Jun 30, 2022 | 8M | +1.3% |
| Q1 FY2022 | Mar 31, 2022 | 8M | +27.5% |
| Q4 FY2021 | Dec 31, 2021 | 8M | +205.0% |
| Q3 FY2021 | Sep 30, 2021 | 8M | +232.8% |
| Q2 FY2021 | Jun 30, 2021 | 8M | +811.3% |
| Q1 FY2021 | Mar 31, 2021 | 6M | +1886.6% |
| Q4 FY2020 | Dec 31, 2020 | 3M | +2227.6% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +2421.9% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +1410.6% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +448.8% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +102.2% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +925.3% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +1762.5% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +5561.4% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +12718.9% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +2051.7% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +1903.3% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +902.0% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +376.4% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?